For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Pilgrim's Pride Corporation (PPC) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-07): Designation Watch · Gem Score +27 (−100…+100 Quality+Value blend) · Quality 16 · Value 34 · Sentiment 6 (timing only, not weighted) · Composite fair value $50.32 vs $31.69 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Pilgrim's Pride Corporation
PPC NASDAQPilgrim's Pride Corporation is a leading poultry and protein products company that produces, processes, markets, and distributes fresh, frozen, and value-added chicken and pork products. Pilgrim's Pride serves retailers, foodservice operators, distributors, and other customers across the United States, Mexico, the United Kingdom, Ireland, and continental Europe. Its business spans core chicken operations alongside prepared foods and branded offerings, supporting a broad range of everyday grocery and foodservice supply needs. The company also operates protein processing plants and prepared foods facilities that help it manage product quality, consistency, and distribution across regional markets. Pilgrim's Pride plays a significant role in the packaged meats and poultry sector through its large-scale production and diversified customer base.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.54
Total Equity: $3.69B
Shares: 238,449,000
Total Debt: $3.09B
Cash: $640.24M
EBITDA: $2.07B
Total Debt: $3.09B
Cash: $640.24M
Revenue: $18.50B
Revenue: $18.50B
Revenue: $18.50B
Total Equity: $3.69B
Tax Rate: 27.9%
Equity: $3.69B
Total Debt: $3.09B
Cash: $640.24M
Current Liabilities: $2.89B
Long-Term Debt: $3.09B
Total Debt: $3.09B
Total Equity: $3.69B
Shares: 238,449,000
Shares: 238,449,000
CapEx: -$718.50M
Shares: 238,449,000
Stock Price: $31.71
Net Income: $1.08B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 29, 2026 12:07am (39d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $14.8B | $17.5B | $17.4B | $17.9B | $18.5B |
| Cost of Revenue | $13.4B | $15.7B | $16.2B | $15.6B | $16.1B |
| Gross Profit | $1.4B | $1.8B | $1.1B | $2.3B | $2.4B |
| Operating Expenses | $1.2B | $635.2M | $596.1M | $806.7M | $744.6M |
| Operating Income | $211.2M | $1.2B | $522.3M | $1.5B | $1.6B |
| Net Income | $31.0M | $745.9M | $321.6M | $1.1B | $1.1B |
| EBITDA | $592.0M | $1.6B | $942.2M | $1.9B | $2.1B |
| EPS | $0.13 | $3.11 | $1.36 | $4.58 | $4.56 |
| EPS (Diluted) | $0.13 | $3.10 | $1.36 | $4.57 | $4.54 |
Balance Sheet (Annual)
Last updated: Aug 29, 2026 12:00am (39d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $427.7M | $401.0M | $697.7M | $2.0B | $640.2M |
| Total Current Assets | $3.3B | $3.9B | $4.2B | $5.1B | $4.2B |
| Total Assets | $8.9B | $9.3B | $9.8B | $10.7B | $10.3B |
| Current Liabilities | $2.4B | $2.6B | $2.5B | $2.6B | $2.9B |
| Long-Term Debt | $3.2B | $3.2B | $3.3B | $3.2B | $3.1B |
| Total Liabilities | $6.3B | $6.4B | $6.5B | $6.4B | $6.6B |
| Total Equity | $2.6B | $2.9B | $3.3B | $4.3B | $3.7B |
| Retained Earnings | $1.0B | $1.7B | $2.1B | $3.2B | $2.2B |
Cash Flow (Annual)
Last updated: Aug 29, 2026 12:17am (39d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $326.5M | $669.9M | $677.9M | $2.0B | $1.4B |
| Capital Expenditure | -$381.7M | -$487.1M | -$557.8M | -$458.5M | -$718.5M |
| Free Cash Flow | -$55.2M | $182.8M | $120.1M | $1.5B | $653.2M |
| Acquisitions (net) | -$966.8M | -$9.7M | $0 | $0 | — |
| Net Debt Issued / (Repaid) | $945.5M | -$25.8M | $151.9M | -$152.1M | -$115.2M |
| Dividends Paid | — | — | $0 | $0 | -$2.0B |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | -$98.3M | -$15.4M | $296.5M | $1.3B | -$1.4B |
Growth Trends (YoY %)
Last updated: Aug 29, 2026 12:07am (39d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +18.2% | -0.6% | +3.0% | +3.5% |
| Gross Profit Growth | +32.7% | -38.3% | +106.8% | +2.0% |
| Operating Income Growth | +457.2% | -55.6% | +188.4% | +7.1% |
| Net Income Growth | +2,306.2% | -56.9% | +237.9% | -0.4% |
| EBITDA Growth | +166.8% | -40.4% | +105.9% | +6.7% |
Dividend History (Last 20)
Last updated: Aug 29, 2026 12:00am (39d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2025-08-20 | $2.10 | — | — | — |
| 2025-04-03 | $6.30 | — | — | — |
| 2016-05-06 | $2.75 | — | — | — |
| 2015-01-28 | $5.77 | — | — | — |
| 2008-09-10 | $0.02 | — | — | — |
| 2008-06-11 | $0.02 | — | — | — |
| 2008-03-12 | $0.02 | — | — | — |
| 2007-12-12 | $0.02 | — | — | — |
| 2007-09-12 | $0.02 | — | — | — |
| 2007-06-13 | $0.02 | — | — | — |
| 2007-03-14 | $0.02 | — | — | — |
| 2006-12-13 | $0.02 | — | — | — |
| 2006-09-13 | $0.02 | — | — | — |
| 2006-06-14 | $0.02 | — | — | — |
| 2006-03-15 | $0.02 | — | — | — |
| 2005-12-14 | $0.02 | — | — | — |
| 2005-09-07 | $0.02 | — | — | — |
| 2005-06-08 | $0.02 | — | — | — |
| 2005-03-09 | $0.02 | — | — | — |
| 2004-12-08 | $0.02 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-10-07 02:03A +1σ run of quarters pays +8%; a −1σ run costs 56%. Ratio 0.1:1 (μ 1.6%, σ 3.8% , 16 pairs).
Older method (repeat-worst-quarter): 6.2 : 1
| Case | Growth | Margin | Fair value | vs price ($31.69) |
|---|---|---|---|---|
| Bull — recovery | -1% | 17.3% | $142.61 | +350% |
| Base — stabilizes | -2% | 15.0% | $120.93 | +282% |
| Bear — keeps slipping | -2% | 12.8% | $100.33 | +217% |
| Stress — last quarter repeats | -3% | 1.5% | $13.82 | -56% |
| Upside — a +1σ run of quarters (v2) | +5% | 3.1% | $34.22 | +8% |
| Stress — a −1σ run of quarters (v2) | -2% | 1.5% | $14.07 | -56% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-29 00:44The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The quarterly trajectory is the story everyone's underweighting. Q3 2024 net income was $349.9M on $4.58B revenue (7.6% margin); Q2 2025 hit $355.5M on $4.76B (7.5%); then Q4 2025 collapsed to $88M (1.9%), Q1 2026 recovered to $101.4M (2.2%), and Q2 2026 cratered to $13.4M on $4.63B — a 0.3% margin. That's not "margin normalization already occurred" as the thesis engine claims; that's active, ongoing margin compression happening right now. The TTM earnings run-rate implied by the last four quarters is roughly $545M, not the $1.08B FY2025 print the P/E of 6.98 is anchored to. Recalculate: at $545M TTM earnings and $7.41B market cap, the real forward P/E is closer to 13.6x, not 7x. The synthesis verdict of "undervalued at $42.65" is leaning heavily on stale FY2025 earnings that included two blowout quarters now in the rearview.
That said, the bear case has its own problem: PPC's five-year history shows 2021 net income of just $31M and 2023 at $321M — meaning the business does trough well below current levels, and $13.4M in a single quarter isn't unprecedented weakness, it's characteristic of the cycle. Free cash flow of $653M on FY2025 is real, debt at $3.09B against $3.69B equity and $1.37B OCF is manageable (net debt/EBITDA well under 2x), and the balance sheet isn't the crisis the bear narrative implies. ROIC of 18.9% across the cycle average isn't a structurally impaired business — it's a well-run scale operator in chicken. The payout ratio of 1.84 is a red flag suggesting the recent special dividend outran sustainable earnings, and I'd expect capital return to slow sharply.
Where I disagree with the prior stack: the classification model calls this "mature_earner" with 0.88 confidence — wrong archetype. This is a cyclical commodity processor, and treating it as a mature earner leads directly to the synthesis engine's mistake of extrapolating peak-cycle earnings. Market Forces has this right ("commodity cycle value trap"), and it directly contradicts the Valuation Synthesis "undervalued" call — the models are talking past each other. The Thesis Evaluation's claim that "margin normalization already occurred" is empirically false given the Q2 2026 print of 0.3%. The contrarian argument the synthesis missed: if you normalize margins to the 10-year average of ~4-5% net margin on $18.5B revenue, you get ~$830M normalized earnings, and at a fair 10-11x cyclical multiple that's $8.3-9.1B market cap or $35-39/share. That's above current price but well below the $42-47 fair values being quoted.
Data gaps worth flagging: the "2026-06-28" and "2026-03-29" quarterly dates look future-dated relative to typical reporting — I'm treating them as the most recent actuals but note the labeling is suspicious. Feed cost inputs (corn, soybean meal) aren't in the file and are the single most important driver of the next four quarters; without them any margin forecast is speculation. The Brazilian and Mexican segment exposure (JBS parent structure, geographic concentration bear point) isn't quantified here. My verdict: PPC is neither the screaming bargain the synthesis says nor the value trap the market forces engine implies — it's a fairly-valued cyclical near mid-cycle fair value, with the recent margin collapse suggesting we're closer to trough than peak, which asymmetrically favors patient buyers but doesn't justify aggressive positioning at $31.71 when normalized fair value is $35-39. I dissent from the "undervalued +34.6%" call — the models are anchoring on stale peak earnings and ignoring the fact that Q2 2026 already tells you the cycle has turned.
GPT Reading
Pilgrim’s Pride screens optically cheap, but the raw numbers say the market is not being irrationally pessimistic; it is discounting a business whose earnings power can collapse very fast. The key fact is not the 7.0x P/E on 2025 earnings, it is the trajectory since the peak quarters. Revenue has held roughly flat at a high level — $4.76B in both 2025-06 and 2025-09, then $4.52B, $4.53B, and $4.63B in the next three quarters — yet net income fell from $355.5M and $342.8M in mid/late 2025 to $88.0M, $101.4M, and then just $13.4M most recently. Margin went from 7.5% to 0.3% in three quarters without any revenue collapse. That is exactly what a commodity processor looks like when the spread turns against it. If the top line can stay above $18B annualized while profits nearly disappear, then trailing earnings and even trailing EBITDA are weak anchors for valuation.
The annual view reinforces that this is not a stable “mature earner” so much as a cyclical spread business. Revenue over 2022-2025 stayed in a narrow $17.4B-$18.5B band, but net income swung from $745.9M in 2022 to $321.6M in 2023, then up to about $1.09B in 2024 and $1.08B in 2025. That is not a compounding earnings stream; it is a margin roller coaster. The latest quarter suggests 2025 was much closer to a high-water mark than a normalized base. On a run-rate basis, the last three quarters sum to only about $202.8M of net income, versus $1.08B for full-year 2025. Even if that understates normalized earnings because the most recent quarter was unusually weak, it still tells you the earnings denominator behind the “cheap” multiples is moving violently lower. Paying 0.41x sales and 4.8x EV/EBITDA is not obviously a bargain when gross margin is only 12.8% in a good year and can translate into near-zero net margin in a bad quarter.
The balance sheet and cash flow are good enough to avoid a disaster case, but not good enough to justify treating the stock as a low-risk value name. Net debt is roughly $2.45B against $3.69B of equity, with debt/equity at 0.84. Operating cash flow of $1.37B and free cash flow of $653.2M in 2025 look solid, but that was earned during a year with 8.7% operating margin and 5.9% net margin; if margins revert toward the latest quarter’s 0.3% net margin or even the latest three-quarter average around 1.5%, FCF will compress hard. In that context, the 2.0x book multiple is not a screaming discount either. ROE of 29.3% and ROIC of 18.9% look excellent on paper, but they are backward-looking and cycle-inflated. I think the right framing is that PPC deserves a low multiple because returns are not durable in the way the headline ratios imply. At $31.71, the stock looks closer to fairly valued on mid-cycle earnings than 30%+ undervalued.
The strongest pushback is obvious: the market may already have priced in most of this collapse. The stock is down from roughly $45 to $32, and on 2024-2025 annual numbers PPC still produced more than $1B of net income in each year, $1.61B of operating income in 2025, and over $650M of free cash flow after a hefty $718.5M of capex. If you assume 2026 is the trough and earnings simply normalize back to something like $700M-$900M, then a $7.4B market cap and roughly $9.9B enterprise value would indeed look cheap. There is also evidence the business is not structurally impaired: revenues are stable, liquidity is adequate with a 1.47 current ratio, and the company has shown it can remain profitable across multiple years despite industry volatility. A smart bull would say the latest quarter is the outlier, not 2025, and that buying protein processors when margins look ugly is precisely how you make money.
What would flip me more positive is not a valuation argument but proof that margins have found a floor. Specifically, I’d want to see at least two consecutive quarters with operating performance recovering meaningfully from the latest trough — net margin back above 3%, quarterly net income comfortably above $150M, and free cash flow holding up without a capex holiday. If PPC can do that while revenue stays around $4.5B-$4.7B, then the 2026 slump starts to look cyclical and temporary rather than evidence that 2024-2025 overstated normalized earnings. Conversely, if another quarter comes in near breakeven despite steady sales, then the stock is not cheap at 7x trailing earnings at all; it is expensive on the earnings power that actually matters.
Grok Reading
The quarterly tape is the whole story, and it is ugly in a way the annual composites still paper over. Pilgrim’s put up $18.50B of revenue and $1.08B of net income in fiscal 2025 with a 5.9% net margin and $653M of free cash flow, which is why a 7.0x P/E, 0.41x sales, and 4.8x EV/EBITDA flash green on every screen. Then the cycle turned hard: net margin fell from 7.5% and 7.2% in mid-2025 to 1.9%, 2.2%, and finally 0.3% by the June 2026 quarter, when $4.63B of sales produced only $13.4M of profit. Trailing four-quarter net income is already down to roughly $546M—half the annual print the multiples are still anchored to—and the sequential path is still down. Revenue is not the problem (still +3% class growth, $4.5–4.8B per quarter); protein pricing and/or feed spreads are. At $31.71 and a $7.41B equity value the stock is no longer “7x peak earnings”; it is closer to 13–14x earnings that are still deteriorating, against $3.09B of debt and only $640M of cash.
That is exactly the commodity mean-reversion the market thesis described, and it is happening in real time rather than as a hypothetical. Operating cash flow of $1.37B and a still-positive FCF after $719M of capex give the balance sheet a pulse, and ROE/ROIC of 29%/19% on the annual base show what the assets earn when spreads cooperate. But a payout ratio above 1.8x and debt-to-equity of 0.84 leave little room if the 0.3% margin quarter is a waystation rather than the trough. The valuation synthesis that spits out $42–47 is using the wrong denominator; it treats 2025’s $1.08B as durable when three straight quarters have already rejected that premise. On a mid-cycle net margin of something like 3–4% ($550–750M), $31.71 is roughly 10–13x normalized earnings and about 0.4x sales—cheap enough for a scaled processor, not a gift.
The strongest pushback is the classic cyclical one: you buy poultry when margins are crushed and P/S is in the 0.4x handle, not when net income is $350M a quarter. A smart opponent will note that 2021’s near-zero year and 2023’s $322M net already proved the trough is survivable, that EV/sales of 0.54x embeds almost no recovery, and that any normalization back even halfway toward 2024–25 profitability re-rates the equity hard because fixed-cost leverage works in both directions. They will also argue $653M of FCF against a $7.4B market cap is an 8%+ free-cash yield at the trough, which is why the no-growth floor arguments keep firing. I weigh that less than the opponent does because the fade is not finished in the printed numbers—June’s 0.3% margin is an acceleration lower, not a base—and because leverage plus a >100% payout ratio turn a multi-quarter soft patch into equity risk rather than a clean mean-reversion coupon. The discount is earned; it is not automatically alpha.
I would flip constructively bullish on two consecutive quarters of net margin back above ~3.5% with stable revenue, or on a clear deleveraging print that takes net debt meaningfully under 1.5x run-rate EBITDA while FCF holds above $500M. I would flip outright bearish if another sub-1% net quarter arrives or if cash burns enough to threaten the credit metrics. Until one of those shows up, the stock is a low-conviction value claim, not a high-conviction mispricing.
Qwen Reading local experiment · off-panel
The single most important number in this briefing is not the 6.0x P/E or the 2.8x EV/EBITDA — it's the quarterly net income trajectory: $342.8M in September 2025, $88.0M in December 2025, $101.4M in March 2026. That is a 70% collapse in two quarters on essentially flat revenue ($4.76B → $4.52B → $4.53B). The "recovery" that the 2024-2025 annual numbers celebrate — gross margin jumping from 6.4% in 2023 to 12.8% in 2025 — is already reversing in real time. The market's 46% drawdown from highs is not a mispricing; it is the market watching the margin cycle turn and adjusting. The valuation synthesis calling this a 154% upside opportunity at a $63-70 fair value is applying a DCF to peak-cycle earnings of a commodity poultry processor with 3.2% revenue CAGR and zero pricing power. That is not a valuation; that is a math error dressed in a spreadsheet.
What I do credit to the bull case, and what the bear narrative gets wrong, is the balance sheet. Total debt of $924K against $640.2M in cash and $3.69B in equity is not the "overleveraged JBS hangover" that the fallen-angel narrative describes. They have spent four years and roughly $1.37B in annual operating cash flow to strip the leverage off the capital structure. Debt-to-equity of 0.0003 means the refinancing-risk and covenant-breach scenarios that anchor the bear story are essentially irrelevant. That $640M in cash is roughly $1.05 per share, or about 4% of the current market cap, and it is a genuine floor that the 2021-2023 "financial distress" framing does not account for. The payout ratio of 1.84x is a real concern — they are distributing more than they earn — but with that cash cushion, the dividend is fundable for several years even if earnings crater to 2023 levels.
The contradiction I find most telling is between the "mature earner" archetype (confidence 0.88) and the actual earnings CAGR of 83.5% and FCF CAGR of 133.2%. Those growth rates are not organic; they are the mechanical result of a trough-to-peak cycle in feed costs and bird-flu disruption. Revenue has grown 3.2% per year over five years. This is a company that processes 4.5 billion pounds of chicken a year and cannot grow its top line. The 38.1% ROIC and 29.3% ROE are peak-cycle artifacts that will compress toward 8-12% as margins normalize. The "sector leader" tag is doing a lot of narrative work in the secondary signals, but a sector leader in commodity poultry processing is not the same as a sector leader in, say, semiconductors. The moat is vertical integration and scale, not brand or switching costs.
The strongest case against my own skepticism is the absolute price. At $27.36, you are buying a company with $18.5B in revenue, $640M in net cash, and a business that generated $1.08B in net income last year for $6.5B. Even if I haircut earnings 50% to $540M (roughly 2023 levels), the P/E is 12x on a consumer-staples-adjacent business with a clean balance sheet. The 0.35x price-to-sales is below the replacement cost of the processing plants, feed mills, and distribution network. A rational acquirer or activist would see the $640M cash plus the operating asset base as worth more than the current market cap. The "neutral market forces" signal undersells how unusual it is for a company with this balance sheet to trade at a 40% discount to even its trough-earnings DCF.
What would flip me: I need to see Q2 2026 (the June quarter) net income above $200M with gross margin back above 9%. If it comes in at $80M again, the margin collapse is structural, not cyclical, and the 6x P/E is a value trap because the denominator is an illusion. I also need to see management address the 1.84x payout ratio — if they cut the dividend to match a $400M earnings run-rate, that removes the cash-burn overhang and actually strengthens the case. A special dividend funded by the $640M cash would be the single most bullish signal I could get, because it would confirm management believes the balance sheet is the real asset. Conversely, any announcement of new capex commitments above the current $718M annual run-rate, or a new debt issuance, would tell me the "clean balance sheet" story is a temporary artifact and I'd exit.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Pilgrim's Pride is a mature packaged-foods/protein processor showing a sharp margin recovery: gross margin swung from 6.4% in 2023 to 12.9% in 2024 and held 12.7% in 2025, with operating margin at 8.7% and net income of $1.08B on $18.5B revenue. Earnings quality checks are clean — OCF/NI of 3.33x, accruals at -3.5% of assets, Beneish M of -2.43, and Altman Z of 3.43 in the safe zone. FCF of $653M in 2025 (down from $1.53B in 2024, likely working-capital normalization) funds the business without external capital. Share count has actually declined slightly (-0.6% CAGR) with negligible SBC at 0.2% of revenue, so per-share value is being protected, not eroded. The main structural constraint is $2.45B of net debt against $640M cash; leverage is workable at current earnings power but becomes a real issue if the protein cycle rolls over. History confirms the cyclicality — 2021 operating margin was 1.4% and FCF was negative, so today's 8.7% margin should not be underwritten as the through-cycle norm. This is a well-run cyclical at or near a cycle peak, with clean books and disciplined capital behavior, but not a fortress.
Verify before trusting this (6)
- Debt maturity schedule and covenants against 2.45B net debt
- Segment mix (US chicken vs Prepared Foods vs Europe/Mexico) and customer concentration
- JBS parent-related-party transactions and governance controls
- Sustainability of 2024-2025 margin — feed cost trends and pricing
- Capex plans; whether 2024 FCF spike vs 2025 drop was working capital or capex-driven
- Special dividend or capital return policy (given no buyback but shrinking share count)
The composite fair value of $47.30 and signal-adjusted $42.65 imply 35% and ~35% upside from $31.69. The three methods bracket sensibly: DCF $52.34, anchored-PE $44.45, EPV floor $40.06. The tight clustering, plus an EPV floor still well above the current price, is the strongest tell here — even the conservative earnings-power method says the stock is undervalued by roughly 20-25%. Quality is graded Strong and earnings quality is high, so I do not haircut the deserved value further.
Verify before trusting this (4)
- Feed cost trajectory and chicken cutout spreads in latest quarter
- Management commentary on margin sustainability vs mid-cycle normalization
- Net debt trajectory and refinancing schedule
- Any one-off gains inflating current earnings power
PPC lives in the least sentiment-sensitive corner of the market: a 0.27-beta packaged-foods name with a moderate-intensity, low-cult 'steady compounder' narrative. The risk-on tape (+35, VIX 14) does almost nothing for this name because it doesn't participate in beta-led rallies, and conversely macro-headwind pressure from 4.67% 10y yields barely lands on a defensive protein processor. The dominant force here is idiosyncratic: a +6% post-earnings drift over the last month suggests the tape is quietly digesting the print constructively, but there is no active narrative catalyst pulling in fresh momentum buyers. News flow is thin and largely tangential (an unrelated ASX-listed PPC dominates the headlines), which means the story is neither breaking nor building. The bull-bear split is fundamental, not sentiment-driven: the 25% DCF discount reflects real balance-sheet and commodity-spread concerns, not a narrative de-rating. Analyst tone is not flagged as bifurcated. Net: a slight positive drift from the earnings reaction and improving leverage (D/E 1.00 to 0.84) is roughly offset by the absence of any narrative tailwind and mild macro-rate pressure on a levered commodity operator. This is a name the tape is largely ignoring, which for a discounted defensive is neither a headwind nor a real tailwind.
Verify before trusting this (4)
- Whether the post-earnings drift extends or fades into the next print - a stall would confirm the market has priced the good quarter
- Feed cost / grain complex moves that could reignite the commodity-spread bear story
- Any sell-side target revisions post-earnings that could crystallize an upgrade cycle
- Sector rotation into defensives if the risk-on tape cracks - would finally give PPC a bid it currently lacks
The world is unusually kind to chicken demand and unusually harsh to chicken pricing at the same time. A historically small US cattle herd has pushed beef to records, driving trade-down into poultry, while large grain crops keep feed cheap — both support mid-cycle profitability. Against that, the extraordinary 2024-25 breast-meat pricing that produced peak earnings drew an industry supply response, and that supply is now arriving into a consumer that is value-seeking and a foodservice channel with softening traffic. Macro headwinds (10y at 4.67%) matter mainly through PPC's leverage and capex cost, not demand — protein consumption is the most defensive line in the grocery basket. Net: volume floor is solid, price/mix is the variable, and earnings power over 2-3 years should settle above the pre-2023 base but well below the 2025 peak.
When we made this prediction on Aug 29, 2026, PPC was $31.69. We expect it to be $37.90 by Mar 2027, and we consider it great value under $28.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 29, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.
Post-Report Due Diligence NOTES
Evidence for a closer look, not a verdict — no score or designation on this page has been changed by it. Items marked material are ones where a conclusion above moves to the other side of the price.
adjusted_earnings
flips down 25%
cost_of_capital
flips up 25%
shares
flips up 25%